哈药集团诚招国外医药企业委托加工业务

　　哈药集团有限公司是中国最大的制药企业集团之一，拥有2家上市公司，13个全资子公司。集团所属医药生产企业均已通过中国国家食品药品监督管理局的GMP认证，重点企业通过了ISO9000和ISO14000体系认证。作为世界知名的中国制药企业集团，哈药集团拥有诸多著名商标品牌，其中“哈药”品牌已经中国权威机构评估价值106.35亿元人民币。

哈药集团科研开发实力雄厚，具有一个国家级企业技术中心为核心的新药研究院和抗生素、现代中药、新型制剂等三个研究中心。哈药集团生产企业产品技术装备先进，主导产品的各项经济技术指标处于国际或国内领先水平，部分头孢类医药原料药及制剂和青霉素原粉及制剂的技术指标及产销量处于国内领先地位，并在南非、苏丹、欧洲、印度、俄罗斯、美国及中东地区和国家取得了进口注册。哈药集团医药产品生产能力强大，现已具备年产抗生素原料药5000吨，粉针30多亿支，水针2亿支，口服液20亿支，片剂150亿片，胶囊50亿粒的产业规模。哈药集团的产品多次参加了联合国药品招标采购活动，哈药集团的生产企业已经成功地与国外医药厂商合作开展了委托加工业务。

我们真诚的希望国外医药厂商，跨国医药企业，走进哈药集团—您转移产品生产基地的理想合作伙伴，开展来样加工，来料加工，多种形式的委托加工合作业务，实现互惠互利，共同发展。

公司网址：www.hayao.com

公司地址：中国哈尔滨市道里区友谊路431号

公司电话：0451-84856671公司传真：0451-84837625

联系人：刘志斌于文佩电子邮件：liuzhb@hayao.com

Inviting Business in Our Offer of Processing

Harbin Pharmaceutical Group Holding Co., Ltd., is one of the largest pharmaceutical manufacture enterprises in China, which owns two holding listed companies and 13 full-capital sub-companies. All manufacturers of the Group have obtained the GMP certificates issued by SFDA and the leading companies have obtained ISO9000 certificates and ISO14000 certificates. As a famous pharmaceutical enterprises group in China, the Group owns many well-known Trade Marks and Brands, among them “HAYAO” Brand values RMB 10.635 billion yuan estimated by China’s authority.

Harbin Pharmaceutical Group with rich scientific research and technological development has a New Medicine Research Institute that takes state grade technique center as the core, also has three research centers including AntibioticResearchCenter, ModernMedicineResearchCenter and ResearchCenter for New Type of Preparation Form. With the advanced production and technique equipments, the economical indexes and technical indexes for the Group`s dominant products have reached international advanced level or domestic advanced level. Some cephalosporin products and penicillin products have taken up a superior position in domestic market and been exported to many regions and countries in the world such as South Africa, Sudan, Europe, India, Russia, U.S.A. Iran and so on. Harbin Pharmaceutical Group has such a big annual production capacity as follows: Antibiotics raw materials: 5000 tons, Powder injection: more than 3 billion vials, Liquid injection: 0.2 billion vials, Oral liquid: 2 billions vials, Tablet: 15 billion tablets, Capsule: 5 billion pills. The manufacturers of Group had produced some kinds of medicines for UN Buying in China and have been producing medicines with supplied materials or with supplied samples for abroad customers.